Astellas Pharma Inc

This study tested whether a daily pill called enzalutamide could slow down advanced prostate cancer that had spread and was no longer responding to standard hormone therapy. It involved 395 Asian men whose cancer had progressed but who had not yet received chemotherapy. Participa…

This study tested whether adding an experimental drug called OSI-906 to the standard drug Tarceva could better control advanced non-small cell lung cancer in patients with specific genetic mutations. It involved 88 patients who had not yet received chemotherapy for their advanced…

This study tested whether adding an experimental drug called OSI-906 to an existing lung cancer drug (erlotinib) could help keep advanced lung cancer from getting worse for a longer time. It involved 205 adults whose cancer had not progressed after four rounds of standard chemoth…

This was an early safety study to test a new drug called ASKP1240 in people who recently received a kidney transplant. The main goal was to see how the drug moves through the body, how it affects the immune system, and if it is safe and tolerable. The study involved 50 participan…

This study tested whether adding a new targeted drug called gilteritinib to standard chemotherapy was safe and effective for people newly diagnosed with acute myeloid leukemia (AML), a fast-growing blood cancer. The first part of the study aimed to find the safest dose. The secon…

This study tested whether fezolinetant, a non-hormonal medication, reduces hot flashes in Japanese women going through menopause. 410 participants were randomly assigned to receive either a low or high dose of the drug or a placebo pill for 12 weeks. Women tracked their symptoms …